Biocryst Pharmaceuticals Inc
$7.86
+$0.03 (+0.38%) Day
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with hereditary angioedema and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. The RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older.
Find out what a historical investment in Biocryst Pharmaceuticals Inc would be worth today using our BCRX stock calculator.
$1.64B
-
0.00%
1.79M
$7.93
$7.69
$7.82
$9.50
$4.03
Ready to start your investing journey with Stake?
Open an accountBCRX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BCRX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BCRX
on Stake
Buy BCRX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of BCRX from only US$10 with fractional shares
